Skip to Content

APO 25 250 (Carbidopa and Levodopa 25 mg / 250 mg)

Pill with imprint APO 25 250 is Blue, Round and has been identified as Carbidopa and Levodopa 25 mg / 250 mg. It is supplied by Apotex Corporation.

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 25 250

Carbidopa and levodopa 25 mg / 250 mg APO 25 250
Carbidopa and levodopa 25 mg / 250 mg APO 25 250
Carbidopa and levodopa 25 mg / 250 mg APO 25 250

Carbidopa and Levodopa

Imprint
APO 25 250
Strength
25 mg / 250 mg
Color
Blue
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corporation
National Drug Code (NDC)
60505-0130
Inactive Ingredients
magnesium stearate, sodium bicarbonate, FD&C Blue No. 1, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "APO 25 250"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.